What's Happening?
Nationwide Children’s Hospital has announced the appointment of Dr. Can Yerebakan, MD, PhD, as the new chief of its Department of Cardiothoracic Surgery, effective this month. Dr. Yerebakan joined Nationwide Children's in 2024 as the associate chief of the Department of Cardiothoracic Surgery and
director of the Congenital CT Surgery Fellowship. His predecessor, Dr. Mark Galantowicz, co-director of The Heart Center, praised Dr. Yerebakan's leadership and contributions since his arrival, highlighting his skill as a congenital heart surgeon and his embrace of the Heart Center's multidisciplinary culture. Dr. Yerebakan's research primarily focuses on the fetal development of single ventricle congenital heart disease, and he is a principal investigator at the Abigail Wexner Research Institute at Nationwide Children’s Hospital. Before joining Nationwide Children's, he served as the associate chief of Cardiovascular Surgery at Children’s National Hospital in Washington, D.C., and was a professor of surgery and pediatrics at the George Washington University School of Medicine and Health Sciences. He has an extensive publication record with over 170 peer-reviewed articles and more than 200 presentations globally.
Why It's Important?
The appointment of Dr. Can Yerebakan as Chief of Cardiothoracic Surgery at Nationwide Children's Hospital signifies a continuation and potential advancement in pediatric cardiac care and research. Nationwide Children's is recognized as one of the largest not-for-profit free-standing pediatric health care systems in the U.S., with a strong focus on pediatric population health, behavioral health, genomics, and health equity. Dr. Yerebakan's expertise in congenital heart surgery and his active research in fetal development of single ventricle congenital heart disease are crucial for addressing complex pediatric cardiac conditions. His leadership is expected to build upon the existing foundation of the Heart Center, which is vital for families seeking specialized care for children with heart defects. The hospital's role in training future pediatric specialists through its affiliation with The Ohio State University College of Medicine means that advancements under Dr. Yerebakan's leadership could influence pediatric cardiology practices nationwide. His extensive academic contributions and involvement in professional organizations underscore the hospital's commitment to leading-edge medical practice and research, ultimately impacting patient outcomes and the broader medical community.
What's Next?
Following Dr. Yerebakan's appointment, Nationwide Children's Hospital is expected to continue its focus on advancing pediatric cardiothoracic surgery and research. His leadership will likely involve further integration of clinical and research programs, particularly in the area of congenital heart disease. The hospital will aim to build on the strong foundation established by Dr. Galantowicz, potentially expanding its clinical offerings and research initiatives. Dr. Yerebakan's role as director of the Congenital Heart Surgery Fellowship suggests a continued emphasis on recruiting and training highly skilled surgeons, which will bolster the hospital's capacity for complex procedures and contribute to the national pool of pediatric cardiac specialists. Future developments may include new research findings from his work at the Abigail Wexner Research Institute, potentially leading to innovative treatments or diagnostic methods for congenital heart conditions. The hospital's commitment to quality and safety, combined with Dr. Yerebakan's expertise, indicates a trajectory of continuous improvement in patient care and medical education.
Beyond the Headlines
Dr. Yerebakan's appointment reflects a broader trend in specialized pediatric healthcare towards integrating advanced surgical expertise with robust research programs. His focus on the fetal development of single ventricle congenital heart disease highlights the increasing importance of early intervention and understanding the origins of complex conditions. This approach not only aims to improve surgical outcomes but also to potentially develop preventative strategies or earlier diagnostic tools. The emphasis on a multidisciplinary culture within the Heart Center, as noted by Dr. Galantowicz, points to the collaborative nature required for treating intricate pediatric cases, involving cardiologists, surgeons, researchers, and other specialists. This collaborative model is crucial for addressing the holistic needs of pediatric patients and their families. Furthermore, the hospital's commitment to diversity and inclusion, as an equal opportunity employer, suggests an environment that values varied perspectives in medical practice and research, which can foster innovation and improve patient care for a diverse population.
